Cancer Research Donn Young Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bond, G. L.
Right arrow Articles by Levine, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bond, G. L.
Right arrow Articles by Levine, A.
Related Collections
Right arrow Epidemiology and Prevention
Right arrow Epidemiology and Prevention: Genetics and Biomarkers
[Cancer Research 65, 5481-5484, July 1, 2005]
© 2005 American Association for Cancer Research

Review Articles

A Single Nucleotide Polymorphism in the MDM2 Gene: From a Molecular and Cellular Explanation to Clinical Effect

Gareth L. Bond, Wenwei Hu and Arnold Levine

The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey and The Institute for Advanced Studies, Princeton, New Jersey

Requests for reprints: Arnold J. Levine, Institute for Advanced Study, School of Natural Sciences, Einstein Drive, Princeton, NJ 08540. Phone: 212-327-8080; Fax: 1-212-327-8900; E-mail: alevine{at}ias.edu.

In a recent article, a candidate pathway approach was taken to try to identify single nucleotide polymorphisms (SNP) that make up the genetic variation, which underlies the phenotypic variation seen between individuals in their susceptibility to cancer and the progression of their disease. The p53 stress response pathway was chosen given its well-documented importance in tumor suppression. A SNP was found which associates with the attenuation of the p53 pathway and the acceleration of tumor formation in humans and data was presented which describe a molecular mechanism for these phenotypes.




This article has been cited by other articles:


Home page
 Clin. Cancer Res.Home page
G. Toffoli, P. Biason, A. Russo, E. De Mattia, E. Cecchin, C. M. Hattinger, M. Pasello, M. Alberghini, C. Ferrari, K. Scotlandi, et al.
Effect of TP53 Arg72Pro and MDM2 SNP309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and Survival
Clin. Cancer Res., May 15, 2009; 15(10): 3550 - 3556.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
D. W. Cescon, P. A. Bradbury, K. Asomaning, J. Hopkins, R. Zhai, W. Zhou, Z. Wang, M. Kulke, L. Su, C. Ma, et al.
p53 Arg72Pro and MDM2 T309G Polymorphisms, Histology, and Esophageal Cancer Prognosis
Clin. Cancer Res., May 1, 2009; 15(9): 3103 - 3109.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
G. Klein
Toward a genetics of cancer resistance
PNAS, January 20, 2009; 106(3): 859 - 863.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
A. Shlien, U. Tabori, C. R. Marshall, M. Pienkowska, L. Feuk, A. Novokmet, S. Nanda, H. Druker, S. W. Scherer, and D. Malkin
Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome
PNAS, August 12, 2008; 105(32): 11264 - 11269.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S. Cattelani, R. Defferrari, S. Marsilio, R. Bussolari, O. Candini, F. Corradini, G. Ferrari-Amorotti, C. Guerzoni, L. Pecorari, C. Menin, et al.
Impact of a Single Nucleotide Polymorphism in the MDM2 Gene on Neuroblastoma Development and Aggressiveness: Results of a Pilot Study on 239 Patients
Clin. Cancer Res., June 1, 2008; 14(11): 3248 - 3253.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Z. Hu, G. Jin, L. Wang, F. Chen, X. Wang, and H. Shen
MDM2 Promoter Polymorphism SNP309 Contributes to Tumor Susceptibility: Evidence from 21 Case-Control Studies
Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2717 - 2723.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
S. Wilkening, J. L. Bermejo, and K. Hemminki
MDM2 SNP309 and cancer risk: a combined analysis
Carcinogenesis, November 1, 2007; 28(11): 2262 - 2267.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
M. K. Schmidt, S. Reincke, A. Broeks, L. M. Braaf, F. B.L. Hogervorst, R. A.E.M. Tollenaar, N. Johnson, O. Fletcher, J. Peto, J. Tommiska, et al.
Do MDM2 SNP309 and TP53 R72P Interact in Breast Cancer Susceptibility? A Large Pooled Series from the Breast Cancer Association Consortium
Cancer Res., October 1, 2007; 67(19): 9584 - 9590.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
M. Yang, Y. Guo, X. Zhang, X. Miao, W. Tan, T. Sun, D. Zhao, D. Yu, J. Liu, and D. Lin
Interaction of P53 Arg72Pro and MDM2 T309G polymorphisms and their associations with risk of gastric cardia cancer
Carcinogenesis, September 1, 2007; 28(9): 1996 - 2001.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
T. Terzian, Y. Wang, C. S. Van Pelt, N. F. Box, E. L. Travis, and G. Lozano
Haploinsufficiency of Mdm2 and Mdm4 in Tumorigenesis and Development
Mol. Cell. Biol., August 1, 2007; 27(15): 5479 - 5485.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
H. Hirata, Y. Hinoda, N. Kikuno, K. Kawamoto, Y. Suehiro, Y. Tanaka, and R. Dahiya
MDM2 SNP309 Polymorphism as Risk Factor for Susceptibility and Poor Prognosis in Renal Cell Carcinoma
Clin. Cancer Res., July 15, 2007; 13(14): 4123 - 4129.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
J. Hall, M. Hashibe, P. Boffetta, V. Gaborieau, N. Moullan, A. Chabrier, D. Zaridze, O. Shangina, N. Szeszenia-Dabrowska, D. Mates, et al.
The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract
Carcinogenesis, March 1, 2007; 28(3): 665 - 671.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
N. Dharel, N. Kato, R. Muroyama, M. Moriyama, R.-X. Shao, T. Kawabe, and M. Omata
MDM2 Promoter SNP309 Is Associated with the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis C.
Clin. Cancer Res., August 15, 2006; 12(16): 4867 - 4871.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
G Bougeard, S Baert-Desurmont, I Tournier, S Vasseur, C Martin, L Brugieres, A Chompret, B Bressac-de Paillerets, D Stoppa-Lyonnet, C Bonaiti-Pellie, et al.
Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome
J. Med. Genet., June 1, 2006; 43(6): 531 - 533.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
G. L. Bond, K. M. Hirshfield, T. Kirchhoff, G. Alexe, E. E. Bond, H. Robins, F. Bartel, H. Taubert, P. Wuerl, W. Hait, et al.
MDM2 SNP309 Accelerates Tumor Formation in a Gender-Specific and Hormone-Dependent Manner.
Cancer Res., May 15, 2006; 66(10): 5104 - 5110.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Wilkening, J. L. Bermejo, B. Burwinkel, R. Klaes, C. R. Bartram, A. Meindl, P. Bugert, R. K. Schmutzler, B. Wappenschmidt, M. Untch, et al.
The Single Nucleotide Polymorphism IVS1+309 in Mouse Double Minute 2 Does Not Affect Risk of Familial Breast Cancer
Cancer Res., January 15, 2006; 66(2): 646 - 648.
[Abstract] [Full Text] [PDF]

Home page
 Cold Spring Harb Symp Quant BiolHome page
D.P. LANE
Exploiting the p53 Pathway for the Diagnosis and Therapy of Human Cancer
Cold Spring Harb Symp Quant Biol, January 1, 2005; 70(0): 489 - 497.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.